U.S. markets close in 1 hour 46 minutes
  • S&P 500

    3,779.32
    -11.61 (-0.31%)
     
  • Dow 30

    30,265.72
    -50.60 (-0.17%)
     
  • Nasdaq

    11,104.55
    -71.85 (-0.64%)
     
  • Russell 2000

    1,755.73
    -20.04 (-1.13%)
     
  • Crude Oil

    87.97
    +1.45 (+1.68%)
     
  • Gold

    1,722.50
    -8.00 (-0.46%)
     
  • Silver

    20.58
    -0.52 (-2.46%)
     
  • EUR/USD

    0.9882
    -0.0104 (-1.04%)
     
  • 10-Yr Bond

    3.7710
    +0.1540 (+4.26%)
     
  • GBP/USD

    1.1325
    -0.0150 (-1.30%)
     
  • USD/JPY

    144.5910
    +0.3920 (+0.27%)
     
  • BTC-USD

    20,152.72
    +104.71 (+0.52%)
     
  • CMC Crypto 200

    456.64
    -1.77 (-0.39%)
     
  • FTSE 100

    7,052.62
    -33.84 (-0.48%)
     
  • Nikkei 225

    27,120.53
    +128.32 (+0.48%)
     

Harmony Biosciences Holdings, Inc. (HRMY) Q2 2022 Earnings Call Transcript

·43 min read
Harmony Biosciences Holdings, Inc. (HRMY) Q2 2022 Earnings Call Transcript

At this time, I would like to welcome everyone to the Harmony Biosciences second quarter 2022 financial update conference call. Good morning, everyone, and thank you for joining us today as we review Harmony Biosciences second quarter 2022 financial performance and provide a business update. At this stage of our life cycle, we believe non-GAAP financial results better represent the underlying business performance.